Gastric inhibitory polypeptide (GIP) is selectively decreased in the Roux-limb of dietary obese mice after RYGB surgery

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Zhou, Jiaqiang ^a,b   Hao, Zheng ^b   Irwin, Nigel ^c   Berthoud, Hans Rudolf ^b   Ye, Jianping ^b   Nerurkar, Pratibha V ^d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d UNIVERSITY OF HAWAII AT MANOA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCOSE; INSULIN; MESSENGER RNA; PEPTIDE YY; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET RESTRICTION; FOOD INTAKE; FOOD PREFERENCE; HORMONE BLOOD LEVEL; HORMONE RESPONSE; INSULIN SENSITIVITY; JEJUNUM MUCOSA; LEAN BODY WEIGHT; LIPID DIET; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; POSTPRANDIAL STATE; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; THERAPY EFFECT; WEIGHT REDUCTION; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; BLOOD; DIET; GASTRIC BYPASS SURGERY; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INTESTINE; METABOLISM; MOUSE MUTANT; OBESITY; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIET; GASTRIC BYPASS; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; INTESTINES; MICE; MICE, OBESE; OBESITY; RNA, MESSENGER;

EID: 84942845695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134728     Document Type: Article

References (49)

1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292(14):1724-37. Epub 2004/10/14. 292/14/1724 [pii] doi: 10.1001/jama.292.14.1724 PMID: 15479938.
2. Rubino F, Schauer PR, Kaplan L.M., Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annual review of medicine. 2010; 61:393-411. Epub 2010/01/12. doi:10.1146/annurev.med.051308.105148 PMID: 20059345.
3. Stefater MA, Wilson-Perez HE, Chambers A.P., Sandoval DA, Seeley RJ. All Bariatric Surgeries Are Not Created Equal: Insights from Mechanistic Comparisons. EndocrRev. 2012; 33(4):595-622. Epub 2012/05/03. doi:10.1210/er.2011-1044 PMID: 22550271.
4. Nestoridi E, Kvas S, Kucharczyk J., Stylopoulos N. Resting Energy Expenditure and Energetic Cost of Feeding Are Augmented after Roux-en-Y Gastric Bypass in Obese Mice. Endocrinology. 2012; 153 (5):2234-44. doi: 10.1210/en.2011-2041 PMID: 22416083
5. Hao Z, Zhao Z, Berthoud H-R, Ye J. Development and Verification of a Mouse Model for Roux-en-Y Gastric Bypass Surgery with a Small Gastric Pouch. PLoSONE. 2013; 8(1):e52922. doi: 10.1371/journal.pone.0052922 PMID: 23326365
6. Stylopoulos N, Hoppin AG, Kaplan LM Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity. 2009; 17(10):1839-47. Epub 2009/06/27. doi:10.1038/oby.2009.207 PMID: 19556976.
7. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology. 2010; 138(5):1845-53. Epub 2009/11/26. doi:10.1053/j. gastro.2009.11.012 PMID: 19931268.
8. le Roux CW, Aylwin SJ, Batterham R.L., Borg CM, Coyle F, Prasad V, et al Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006; 243(1):108-14. PMID: 16371744; PubMed Central PMCID: PMC1449984.
9. le Roux CW, Welbourn R, Werling M., Osborne A, Kokkinos A, Laurenius A, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007; 246(5):780-5. doi:10.1097/SLA.0b013e3180caa3e3 PMID: 17968169.
10. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery. 2007; 3(6):597-601. Epub 2007/10/16. doi:10.1016/j.soard.2007.08.004 PMID: 17936091; PubMed Central PMCID: PMC2134840.
11. Karra E, Yousseif A, Batterham RL. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab. 2010; 21(6):337-44. doi:10.1016/j.tem.2010. 01.006 PMID: 20133150.
12. Berthoud HR, Shin AC, Zheng H. Obesity surgery and gut-brain communication. Physiol Behav. 2011; 105(1):106-19. doi:10.1016/j.physbeh.2011.01.023 PMID: 21315095; PubMed Central PMCID: PMC3118403.
13. Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, Fauveau V, et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes. 2011; 60(3):810-8. Epub 2011/02/05. doi:10.2337/db10-0566 PMID: 21292870; PubMed Central PMCID: PMC3046841.
14. Hao Z, Munzberg H, Rezai-Zadeh K, Keenan M, Coulon D, Lu H, et al. Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery. Int J Obes (Lond). 2015; 39(5):798-805. doi:10.1038/ijo.2014.189 PMID: 25349056.
15. Mokadem M, Zechner JF, Margolskee R.F., Drucker DJ, Aguirre V. Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Molecular metabolism. 2013; 3(2):191-201. doi:10.1016/j.molmet.2013.11.010 PMID: 24634822; PubMed Central PMCID: PMC3953682.
16. Ye J, Hao Z, Mumphrey M.B., Townsend RL, Patterson LM, Stylopoulos N, et al GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul IntegrComp Physiol. 2014; 306 (5):R352-62. Epub March, 2014. doi:10.1152/ajpregu.00491.2013 PMID: 24430883.
17. Paschetta E, Hvalryg M, Musso G. Glucose-dependent insulinotropic polypeptide: from pathophysiology to therapeutic opportunities in obesity-associated disorders. Obesity reviews: an official journal of the International Association for the Study of Obesity. 2011; 12(10):813-28. Epub 2011/08/06. doi:10.1111/j.1467-789X.2011.00897.x PMID: 21815989.
18. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nature medicine. 2002; 8(7):738-42. Epub 2002/06/18. doi:10.1038/nm727 PMID: 12068290.
19. Goldfine AB, Mun EC, Devine E, Bernier R., Baz-Hecht M, Jones DB, et al Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007; 92(12):4678-85. doi:10.1210/jc.2007-0918 PMID: 17895322.
20. Laferrere B, Heshka S, Wang K, Khan Y., McGinty J, Teixeira J, et al Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007; 30(7):1709-16. doi:10.2337/dc06-1549 PMID: 17416796; PubMed Central PMCID: PMC2743330.
21. Clements RH, Gonzalez QH, Long C.I., Wittert G., Laws HL. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. The American surgeon. 2004; 70 (1):1-4. PMID: 14964537.
22. Klapdor R. Release of gastric inhibitory polypeptide (GIP) and gastrin after a test meal with a low glucose load in patients after BII resection, proximal duodenopancreatectomy (PDP) and jejunoileal bypass. Research in experimental medicine Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie. 1982; 181(1):11-8. PMID: 7134635.
23. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring). 2008; 16(2):298-305. doi:10.1038/oby.2007.83 PMID: 18239636.
24. Kim MK, Lee HC, Lee S.H., Kwon HS, Baek KH, Kim EK, et al The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass. Diabetes Metab Res Rev. 2012; 28(5):439-46. doi:10.1002/dmrr.2297 PMID: 22407971.
25. Kashyap SR, Daud S, Kelly K.R., Gastaldelli A., Win H, Brethauer S, et al Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes(Lond). 2010; 34(3):462-71. doi:10.1038/ijo.2009.254 PMID: 20029383; PubMed Central PMCID: PMC2838991.
26. Whitson BA, Leslie DB, Kellogg T.A., Maddaus MA, Buchwald H, Billington CJ, et al Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res. 2007; 141(1):31-9. doi:10.1016/j.jss.2007.02.022 PMID: 17574036.
27. Shin AC, Zheng H, Townsend R.L., Sigalet DL, Berthoud HR. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology. 2010; 151(4)1588-97. Epub 2010/02/25. doi:10.1210/en.2009-1332 PMID: 20179262; PubMed Central PMCID: PMC2850245.
28. Stemmer K, Bielohuby M, Grayson B.E., Begg DP, Chambers AP, Neff C, et al Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology. 2013; 154(6):2015-24. doi:10.1210/en.2012-2130 PMID: 23554454.
29. Thomas JR, Marcus E. High and low fat food selection with reported frequency intolerance following Roux-en-Y gastric bypass. Obes Surg. 2008; 18(3):282-7. doi:10.1007/s 11695-007-9336-3 PMID: 18214629.
30. Olbers T, Bjorkman S, Lindroos A., Maleckas A, Lonn L, Sjostrom L., et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006; 244(5):715-22. doi:10.1097/01.sla. 0000218085.25902.f8 PMID: 17060764; PubMed Central PMCID: PMC1856598.
31. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, Mynatt R, et al. Uncoupling of Inflammation and Insulin Resistance by NF-kB in Transgenic Mice through Induction of Energy Expenditure. J Biol Chem. 2010; 285:4637-44. Epub Online Dec 17th 2009. doi: 10.1074/jbc.M109.068007 PMID: 20018865
32. Parker HE, Habib AM, Rogers G.J., Gribble FM, Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia. 2009; 52(2):289-98. doi:10.1007/s00125-008-1202-x PMID: 19082577.
33. Cho YM, Kieffer TJ. K-cells and glucose-dependent insulinotropic polypeptide in health and disease. Vitam Horm. 2010; 84:111-50. doi:10.1016/B978-0-12-381517-0.00004-7 PMID: 21094898.
34. Fujita Y, Wideman RD, Asadi A, Yang GK, Baker R, Webber T, et al. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion. Gastroenterology. 2010; 138(5)1966-75. doi:10.1053/j.gastro.2010.01.049 PMID: 20138041.
35. Deacon CF, Nauck MA, Meier J, Hucking K, Holst JJ. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab. 2000; 85(10):3575-81. doi:10.1210/jcem.85.10.6855 PMID: 11061504.
36. Irwin N, Gault V, Flatt PR. Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease? Expert Opin Investig Drugs. 2010; 19(9):1039-48. doi:10.1517/13543784.2010.513381 PMID: 20698813.
37. Morgan LM, Tredger JA, Hampton S.M., French AP, Peake JC, Marks V. The effect of dietary modification and hyperglycaemia on gastric emptying and gastric inhibitory polypeptide (GIP) secretion. Br J Nutr. 1988; 60(1):29-37. PMID: 3408703.
38. Yoshidome K, Miyata M, Izukura M., Mizutani S, Sakamoto T, Tominaga H., et al. Secretion of gastric inhibitory polypeptide in patients with bile duct obstruction. Scand J Gastroenterol. 1995; 30(6):586-9. PMID: 7569768.
39. Spak E, Bjorklund P, Helander HF, Vieth M, Olbers T, Casselbrant A, et al. Changes in the mucosa of the Roux-limb after gastric bypass surgery. Histopathology. 2010; 57(5):680-8. doi:10.1111/j.1365-2559.2010.03677.x PMID: 21054493.
40. Buchan AM, Pederson RA, Chan C.B., Brown JC. The effect of massive small bowel resection (MSBR) and small intestinal bypass (JIB) in the raton the enteroinsular axis. Regul Pept. 1983; 7(3):221-32. PMID: 6364262.
41. Berghofer P, Peterson RG, Schneider K, Fehmann HC, Goke B. Incretin hormone expression in the gut of diabetic mice and rats. Metabolism. 1997; 46(3):261-7. PMID: 9054467.
42. Mortensen K, Christensen LL, Holst J.J., Orskov C. GLP-1 and GIParecolocalizedin a subset of endocrine cells in the small intestine. Regul Pept. 2003; 114(2-3):189-96. PMID: 12832109.
43. Chandarana K, Batterham RL Shedding pounds after going under the knife: Metabolic insights from cutting the gut. Nat Med. 2012; 18(5):668-9. doi: 10.1038/nm.2748 PMID: 22561824
44. Yin DP, Gao Q, Ma L.L., Yan W., Williams PE, McGuinness OP, et al. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice. Annals of surgery. 2011; 254(1):73-82. Epub 2011/04/28. doi:10.1097/SLA.0b013e3182197035 PMID: 21522012; PubMed Central PMCID: PMC3115424.
45. Hao Z, Munzberg H, Rezai-Zadeh K, Keenan M., Coulon D, Lu H, et al Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery. Int J Obes (Lond). 2014; Oct 28. doi:10.1038/ijo.2014.189 PMID: 25349056.
46. Lingvay I, Guth E, Islam A., Livingston E. Rapid Improvement of Diabetes After Gastric Bypass Surgery: Is It the Diet or Surgery? Diabetes Care. 2013; 36(9):2741-7. Epub 2013/03/27. doi:10.2337/dc12-2316 PMID: 23530013.
47. Jackness C, Karmally W, Febres G, Conwell IM, Ahmed L, Bessler M, et al. Very Low-Calorie Diet Mimics the Early Beneficial Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity and beta-Cell Function in Type 2 Diabetic Patients. Diabetes. 2013; 62(9):3027-32. doi:10.2337/db12-1762 PMID: 23610060; PubMed Central PMCID: PMC3749351.
48. Plum L, Ahmed L, Febres G., Bessler M, Inabnet W, Kunreuther E, et al. Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss. Obesity (Silver Spring). 2011; 19(11):2149-57. doi:10.1038/oby.2011.134 PMID: 21593800; PubMed Central PMCID: PMC3670603.
49. Foo J, Krebs J, Hayes M.T., Bell D., Macartney-Coxson D, Croft T, et al Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery. Obes Surg. 2011; 21(12):1914-20. Epub 2011/10/18. doi:10.1007/s11695-011-0527-6 PMID: 22002509.